Form 4: Charles River Laboratories Executive Sells Shares
SEC Form 4 Filing
Joseph W. LaPlume, EVP at Charles River Laboratories, sold 1,780 shares of common stock on August 8, 2024, at a price of $199.36 per share.
Summary
- On August 8, 2024, Joseph W. LaPlume, an Executive Vice President at Charles River Laboratories, sold 1,780 shares of the company's common stock.
- The sale was executed at a price of $199.36 per share.
- Following the transaction, LaPlume directly owns 22,521 shares of Charles River Laboratories' common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a stock sale by an executive, which is neutral in sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The stock sale by an executive may be perceived differently by stakeholders, with some potentially viewing it as a lack of confidence in the company's future prospects, while others may see it as a normal part of personal financial planning.
Key Dates
| Date | Description |
|---|---|
| 08/08/2024 | Date of stock sale transaction |
| 08/09/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.